Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.
KMID : 1200020180420050425
Diabetes & Metabolism Journal
2018 Volume.42 No. 5 p.425 ~ p.432
The Association between Pancreatic Steatosis and Diabetic Retinopathy in Type 2 Diabetes Mellitus Patients
Jeong Jee-Sun

Kim Mee-Kyung
Han Kyung-Do
Hong Oak-Kee
Baek Ki-Hyun
Song Ki-Ho
Chung Dong-Jin
Lee Jung-Min
Kwon Hyuk-Sang
Abstract
Background: Whether pancreatic steatosis has a local or systemic effect, like ectopic fat of other major organs, remains unknown. Data on the influence of pancreatic steatosis on microvascular complication are rare. Therefore, we investigated the relationship between pancreatic steatosis and diabetic retinopathy (DR) in patients with type 2 diabetes mellitus (T2DM).

Methods: The attenuation of three pancreatic regions (head, body, and tail) and the spleen (S) in 186 patients with T2DM was measured using non-enhanced computed tomography imaging. We used three parameters for the assessment of pancreatic steatosis (¡®P¡¯ mean: mean attenuation of three pancreatic regions; P?S: difference between ¡®P¡¯ mean and ¡®S¡¯; P/S: the ¡®P¡¯ mean to ¡®S¡¯ ratio). The presence of DR was assessed by an expert ophthalmologist using dilated fundoscopy.

Results: The average P mean was 29.02 Hounsfield units (HU), P?S was ?18.20 HU, and P/S was 0.61. The three pancreatic steatosis parameters were significantly associated with the prevalence of DR in non-obese T2DM patients. In the non-obese group, the odds ratios of P mean, P?S, and P/S for the prevalence of DR, after adjustment for age, sex, and glycosylated hemoglobin level, were 2.449 (P=0.07), 2.639 (P=0.04), and 2.043 (P=0.02), respectively.

Conclusion: In this study, pancreatic steatosis was significantly associated with DR in non-obese patients with T2DM. Further studies are necessary to clarify the causal relationship between pancreatic steatosis and the development of DR.
KEYWORD
Diabetes mellitus, type 2, Diabetic retinopathy, Fats, Pancreas
FullTexts / Linksout information
Listed journal information
SCI(E) ÇмúÁøÈïÀç´Ü(KCI) KoreaMed ´ëÇÑÀÇÇÐȸ ȸ¿ø